Ponce, Juliet, N/A. C.
HRN: 23-16-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/21/2023
06/28/2023
IV
1.5 Grams
Q6
Pleural Effusion, Right Secondary To Parapneumonic Process
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes